Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

16.01

-0.39 (-2.38%)

At close: Jun 27, 2025, 4:00 PM

16.00

-0.01 (-0.06%)

After-hours: Jun 27, 2025, 4:04 PM EDT

Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $5.68 billion as of June 27, 2025. Its market cap has increased by 42.12% in one year.

Market Cap

5.68B

Enterprise Value

5.60B

1-Year Change

42.12%

Ranking

#1241

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.68B, an increase of 4,827.39%. That is a compound annual growth rate of 67.06%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	5.68B	11.42%
Dec 31, 2024	5.10B	129.18%
Dec 29, 2023	2.22B	42.30%
Dec 30, 2022	1.56B	-2.70%
Dec 31, 2021	1.61B	96.45%
Dec 31, 2020	817.72M	196.48%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	696.10B
Johnson & Johnson	366.71B
AbbVie	324.15B
Novo Nordisk	299.93B
UnitedHealth Group	279.88B
Novartis AG	235.85B
Abbott Laboratories	233.14B
AstraZeneca	215.99B

Market Cap Rankings